| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
Division of
Neuropathology, University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania; and the Department of Microbiology and
Immunology,
Oregon Health Sciences University,
Portland, Oregon
The blood-brain barrier (BBB) plays a critical role in regulating cell trafficking through the central nervous system (CNS) due to several unique anatomical features, including the presence of interendothelial tight junctions that form impermeable seals between the cells. Previous studies have demonstrated BBB perturbations during human immunodeficiency virus encephalitis (HIVE); however, the basis of these permeability changes and its relationship to infiltration of human immunodeficiency virus type 1 (HIV-1)-infected monocytes, a critical event in the pathogenesis of the disease, remains unclear. In this study, we examined CNS tissue from HIV-1-seronegative patients and HIV-1-infected patients, both with and without encephalitis, for alterations in BBB integrity via immunohistochemical analysis of the tight junction membrane proteins, occludin and zonula occludens-1 (ZO-1). Significant tight junction disruption (P < 0.001), as demonstrated by fragmentation or absence of immunoreactivity for occludin and ZO-1, was observed within vessels from subcortical white matter, basal ganglia, and, to a lesser extent, cortical gray matter in patients who died with HIVE. These alterations were also associated with accumulation of activated, HIV-1-infected brain macrophages, fibrinogen leakage, and marked astrocytosis. In contrast, no significant changes (P > 0.05) were observed in cerebellar tissue from patients with HIVE compared to HIV-seronegative patients or HIV-1-infected patients without encephalitis. Our findings demonstrate that tight junction disruption is a key feature of HIVE that occurs in regions of histopathological alterations in association with perivascular accumulation of activated HIV-1-infected macrophages, serum protein extravasation, and marked astrocytosis. We propose that disruption of this key BBB structure serves as the main route of HIV-1-infected monocyte entry into the CNS.
This article has been cited by other articles:
 |
|
 |
|
  L. E. Gralinski, S. L. Ashley, S. D. Dixon, and K. R. Spindler Mouse Adenovirus Type 1-Induced Breakdown of the Blood-Brain Barrier J. Virol., September 15, 2009; 83(18): 9398 - 9410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murakami, E. A. Felinski, and D. A. Antonetti Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced Permeability J. Biol. Chem., July 31, 2009; 284(31): 21036 - 21046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huang, S. Y. Eum, I. E Andras, B. Hennig, and M. Toborek PPAR{alpha} and PPAR{gamma} attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities FASEB J, May 1, 2009; 23(5): 1596 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Getts, R. L. Terry, M. T. Getts, M. Muller, S. Rana, B. Shrestha, J. Radford, N. Van Rooijen, I. L. Campbell, and N. J.C. King Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis J. Exp. Med., September 29, 2008; 205(10): 2319 - 2337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, J. Sun, and H. Goldstein Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide J. Virol., August 1, 2008; 82(15): 7591 - 7600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhong, E. J. Smart, B. Weksler, P.-O. Couraud, B. Hennig, and M. Toborek Caveolin-1 Regulates Human Immunodeficiency Virus-1 Tat-Induced Alterations of Tight Junction Protein Expression via Modulation of the Ras Signaling J. Neurosci., July 30, 2008; 28(31): 7788 - 7796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Borda, X. Alvarez, M. Mohan, A. Hasegawa, A. Bernardino, S. Jean, P. Aye, and A. A. Lackner CD163, a Marker of Perivascular Macrophages, Is Up-Regulated by Microglia in Simian Immunodeficiency Virus Encephalitis after Haptoglobin-Hemoglobin Complex Stimulation and Is Suggestive of Breakdown of the Blood-Brain Barrier Am. J. Pathol., March 1, 2008; 172(3): 725 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chaudhuri, B. Yang, H. E. Gendelman, Y. Persidsky, and G. D. Kanmogne STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier Blood, February 15, 2008; 111(4): 2062 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Morrey, A. L. Olsen, V. Siddharthan, N. E. Motter, H. Wang, B. S. Taro, D. Chen, D. Ruffner, and J. O. Hall Increased blood brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents J. Gen. Virol., February 1, 2008; 89(2): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schreibelt, G. Kooij, A. Reijerkerk, R. van Doorn, S. I. Gringhuis, S. van der Pol, B. B. Weksler, I. A. Romero, P.-O. Couraud, J. Piontek, et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling FASEB J, November 1, 2007; 21(13): 3666 - 3676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Behling-Kelly, D. McClenahan, K. S. Kim, and C. J. Czuprynski Viable "Haemophilus somnus" Induces Myosin Light-Chain Kinase-Dependent Decrease in Brain Endothelial Cell Monolayer Resistance Infect. Immun., September 1, 2007; 75(9): 4572 - 4581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Reijerkerk, G. Kooij, S. M. A. van der Pol, S. Khazen, C. D. Dijkstra, and H. E. de Vries Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells FASEB J, December 1, 2006; 20(14): 2550 - 2552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Toborek Do not Rho tight junctions (or they become leaky) Blood, June 15, 2006; 107(12): 4581 - 4581. [Full Text] [PDF]
|
|
|
|
|
|
Y. Persidsky, D. Heilman, J. Haorah, M. Zelivyanskaya, R. Persidsky, G. A. Weber, H. Shimokawa, K. Kaibuchi, and T. Ikezu Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE) Blood, June 15, 2006; 107(12): 4770 - 4780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Eugenin, R. Gamss, C. Buckner, D. Buono, R. S. Klein, E. E. Schoenbaum, T. M. Calderon, and J. W. Berman Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J. Leukoc. Biol., March 1, 2006; 79(3): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Eugenin, K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman CCL2/Monocyte Chemoattractant Protein-1 Mediates Enhanced Transmigration of Human Immunodeficiency Virus (HIV)-Infected Leukocytes across the Blood-Brain Barrier: A Potential Mechanism of HIV-CNS Invasion and NeuroAIDS J. Neurosci., January 25, 2006; 26(4): 1098 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Haorah, B. Knipe, J. Leibhart, A. Ghorpade, and Y. Persidsky Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction J. Leukoc. Biol., December 1, 2005; 78(6): 1223 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Hawkins and T. P. Davis The Blood-Brain Barrier/Neurovascular Unit in Health and Disease Pharmacol. Rev., June 1, 2005; 57(2): 173 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wen, D. D. Watry, M. C. G. Marcondes, and H. S. Fox Selective Decrease in Paracellular Conductance of Tight Junctions: Role of the First Extracellular Domain of Claudin-5 Mol. Cell. Biol., October 1, 2004; 24(19): 8408 - 8417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Chang, M. F. Stins, M. J. McCaffery, G. F. Miller, D. R. Pare, T. Dam, M. Paul-Satyasee, K. S. Kim, and K. J. Kwon-Chung Cryptococcal Yeast Cells Invade the Central Nervous System via Transcellular Penetration of the Blood-Brain Barrier Infect. Immun., September 1, 2004; 72(9): 4985 - 4995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Persidsky and H. E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 691 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zenker, D. Begley, H. Bratzke, H. Rubsamen-Waigmann, and H. von Briesen Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells J. Physiol., September 15, 2003; 551(3): 1023 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Luo, K. A. Carlson, V. Wojna, R. Mayo, T. M. Biskup, J. Stoner, J. Anderson, H. E. Gendelman, and L. M. Melendez Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment Neurology, June 24, 2003; 60(12): 1931 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Huber, V. S. Hau, L. Borg, C. R. Campos, R. D. Egleton, and T. P. Davis Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda -carrageenan-induced inflammatory pain Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1531 - H1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Huber, K. A. Witt, S. Hom, R. D. Egleton, K. S. Mark, and T. P. Davis Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1241 - H1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Persidsky, J. Zheng, D. Miller, and H. E. Gendelman Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia J. Leukoc. Biol., September 1, 2000; 68(3): 413 - 422. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
